Melatonin In Acute Mania Investigation (MIAMI-UK). A randomized controlled trial of add-on melatonin in bipolar disorder.
Quested DJ. et al, (2021), Bipolar Disord, 23, 176 - 185
Effects of typhoid vaccine on inflammation and sleep in healthy participants: a double-blind, placebo-controlled, crossover study.
Sharpley AL. et al, (2016), Psychopharmacology (Berl), 233, 3429 - 3435
Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing.
Masaki C. et al, (2016), Psychopharmacology (Berl), 233, 2655 - 2661
Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans.
Singh N. et al, (2016), Neuropsychopharmacology, 41, 1768 - 1778
Effects of the potential lithium-mimetic, ebselen, on brain neurochemistry: a magnetic resonance spectroscopy study at 7 tesla.
Masaki C. et al, (2016), Psychopharmacology (Berl), 233, 1097 - 1104
Pharmacotherapies for sleep disturbances in Alzheimer's disease
McCleery J. et al, (2015), BJ Psych Advances, 21
Pharmacotherapies for sleep disturbances in Alzheimer's disease.
McCleery J. et al, (2014), Cochrane Database Syst Rev
Folic acid supplementation for prevention of mood disorders in young people at familial risk: a randomised, double blind, placebo controlled trial.
Sharpley AL. et al, (2014), J Affect Disord, 167, 306 - 311
In response to "The effect of agomelatine on 5HT(2C) receptors in humans: a clinically relevant mechanism?" by Trevor Norman.
Sharpley AL. and Cowen PJ., (2012), Psychopharmacology (Berl), 221
In response to "the effect of agomelatine on 5HT 2C receptors in humans: A clinically relevant mechanism?" by Trevor Norman
Sharpley AL. and Cowen PJ., (2012), Psychopharmacology, 221
Does agomelatine block 5-HT2C receptors in humans?
Sharpley AL. et al, (2011), Psychopharmacology (Berl), 213, 653 - 655
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.
Wilson SJ. et al, (2010), J Psychopharmacol, 24, 1577 - 1601
An open trial of cognitive therapy for chronic insomnia.
Harvey AG. et al, (2007), Behav Res Ther, 45, 2491 - 2501
Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients.
Sharpley AL. et al, (2005), J Clin Psychiatry, 66, 450 - 454
Olanzapine increases slow wave sleep in SSRI resistant depressed patients
Sharpley AL. et al, (2004), JOURNAL OF PSYCHOPHARMACOLOGY, 18, A14 - A14
Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients.
Sharpley AL. et al, (2003), J Clin Psychiatry, 64, 192 - 196
The effect of Li 1370, extract of Ginkgo biloba, on REM sleep in humans.
Murray BJ. et al, (2001), Pharmacopsychiatry, 34, 155 - 157
Decreased tryptophan availability but normal post-synaptic 5-HT2c receptor sensitivity in chronic fatigue syndrome.
Vassallo CM. et al, (2001), Psychol Med, 31, 585 - 591
Allelic variation in the 5-HT2C receptor (HT2RC) and the increase in slow wave sleep produced by olanzapine.
Sharpley AL. et al, (2001), Psychopharmacology (Berl), 153, 271 - 272
Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo.
Sharpley AL. et al, (2000), Biol Psychiatry, 47, 468 - 470